The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium. [electronic resource]
Producer: 20180315Description: 1929-1938 p. digitalISSN:- 1744-7666
- Benzamides -- therapeutic use
- Bridged-Ring Compounds -- therapeutic use
- Clinical Trials as Topic
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Janus Kinase Inhibitors -- therapeutic use
- Myeloproliferative Disorders -- drug therapy
- Nitriles
- Polycythemia Vera -- drug therapy
- Primary Myelofibrosis -- drug therapy
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- Thrombocythemia, Essential -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.